Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Operating Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,194 Cr₹1,751 Cr₹912 Cr₹264 Cr₹604 Cr

What is the latest Operating Profit of NATCO PHARMA ?

The latest Operating Profit ratio of NATCO PHARMA is ₹2,194 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,194 Cr
Mar2024₹1,751 Cr
Mar2023₹912 Cr
Mar2022₹264 Cr
Mar2021₹604 Cr

How is Operating Profit of NATCO PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,194 Cr
25.26
Mar2024 ₹1,751 Cr
92.10
Mar2023 ₹912 Cr
246.00
Mar2022 ₹264 Cr
-56.36
Mar2021 ₹604 Cr -

Compare Operating Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,072.2 Cr 0.7% -7.1% -26.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 1.7% 4.1% 20.5% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.7%

-7.1%

-26.5%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses